#Japan #Tokyo #Drs MAAs II #MIRAVC #BSB Innovation

Doctor's Choice Achieves Double Victory at BSB Innovation Awards 2026

In an impressive feat for the cosmetics industry, Doctor's Choice, a Tokyo-based company under the leadership of President Akio Yamamoto, has secured dual accolades at the prestigious BSB Innovation Awards 2026. This international awards event took place on April 14, 2026, in Paris, France, and celebrates groundbreaking achievements in cosmetic innovations.

Award-Winning Ingredients

The company’s self-developed cosmetic ingredients received notable recognition, culminating in 'Drs MAAs II' winning first place in the Functional and Additive Materials category, specifically in the UV and Encapsulation section. Meanwhile, 'MIRAVC' clinched third place in the Active Ingredients category, focusing on anti-aging and skin improvement.

Drs MAAs II

Drs MAAs II is derived from mycosporine-like amino acids (MAAs) extracted from blue-green algae. This innovative UV defense ingredient, which emphasizes environmental awareness, was praised for its groundbreaking technology and its efficacy in sun protection. The ingredient’s design aligns with the principles of sustainability and marine conservation, marking a significant step in cosmetic formulation. Judges lauded the unique approach to using natural components, emphasizing that nature serves as our greatest teacher. This accolade underscores the importance of innovation that not only enhances beauty but also supports ecological health.

MIRAVC

On the other hand, MIRAVC represents a neutral vitamin C derivative that stands out due to its low irritation and high stability, addressing challenges prevalent in the beauty industry. Vitamin C has long been revered for its skin benefits; however, high concentrations often lead to irritation and discoloration through oxidation. MIRAVC leverages unique stabilization technology that minimizes skin sensitivity while allowing for concentrated formulations. Additionally, this ingredient has been documented for its efficacy in improving age spots, with findings published in the International Journal of Molecular Sciences in Switzerland.

About the BSB Innovation Awards

Established in 2003, the BSB Innovation Awards are organized by BSB, a cosmetic consulting firm based in Hamburg, Germany. The awards focus on recognizing excellence within the cosmetic industry by highlighting innovative and practical solutions in raw materials and products. This year's awards saw participation from leading global cosmetic manufacturers, ensuring a competitive and thorough evaluation process.

Future Prospects

Looking ahead, Doctor's Choice aims to continue developing unique and effective solutions within the fields of cosmetics, quasi-drugs, and functional foods. The company has recently formed a capital business partnership with Rohto Pharmaceutical Co., Ltd., enabling them to leverage shared expertise and networks to push forward the creation of high-functionality raw materials both domestically and internationally.

Company Overview

Company Name: Doctor's Choice Co., Ltd.
Location: 2-7-2 Fujimi, Chiyoda-ku, Tokyo 102-0071, Japan
Representative: President Akio Yamamoto
Established: May 2006
Website: drs-choice.co.jp
Business Scope: Research and development, manufacturing of cosmetics, quasi-drugs, and functional foods.

For press inquiries, please contact:
Doctor's Choice Co., Ltd.
Contact: Nakano / Nakamura
Email: [email protected]
Phone: 03-6272-6500 (Weekdays 9:00-18:00)